PTEN and colorectal carcinoma: In CRC, mutation and epigenetic inactivation of the PI3K–PTEN pathway occur in up to 40% of cases, and we have shown that Pten deletion rapidly accelerates tumourigenic and drives tumour progression (Marsh et al, 2008).